Comments
Loading...
Summit Therapeutics (NASDAQ:SMMT) Stock, Earnings Estimates, EPS, And Revenue
Summit Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 24
EPS
$-0.070
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Summit Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Summit Therapeutics (SMMT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-24 | $-0.07 | $-0.08 | 12.5 % |
| Q3 | 2024-10-30 | $-0.05 | $-0.07 | 28.6 % |
| Q2 | 2024-08-06 | $-0.05 | $-0.06 | 16.7 % |
| Q3 | 2021-11-15 | $-0.20 | $-0.28 | 28.6 % |
Summit Therapeutics (SMMT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2021-08-11 | $57.00K | $4.45M | -98.7 % |
FAQ
When is Summit Therapeutics (NASDAQ:SMMT) reporting earnings?
Summit Therapeutics (SMMT) is scheduled to report earnings on April 30, 2025. The last reported earnings were for reported on February 24, 2025 for Q4.
What were the latest earnings per share (EPS) for Summit Therapeutics (NASDAQ:SMMT)?
The Actual EPS was $-0.07, which beat the estimate of $-0.08.
What were Summit Therapeutics’s (NASDAQ:SMMT) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.